T
Tania Acosta
Researcher at Universidad del Norte, Colombia
Publications - 18
Citations - 820
Tania Acosta is an academic researcher from Universidad del Norte, Colombia. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 6, co-authored 16 publications receiving 746 citations. Previous affiliations of Tania Acosta include Hospital Universitario La Paz.
Papers
More filters
Journal ArticleDOI
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Bernhard Paulweber,Paul Valensi,Jaana Lindström,N. Lalic,Colin J Greaves,Martin McKee,K. Kissimova-Skarbek,Stavros Liatis,Emmanuel Cosson,Julia Szendroedi,K. E. Sheppard,Kate Charlesworth,A. M. Felton,M. Hall,A. Rissanen,A. Rissanen,Jaakko Tuomilehto,Peter Schwarz,Michael Roden,M. Paulweber,Andreas Stadlmayr,Lyudmyla Kedenko,Nicholas Katsilambros,Konstantinos Makrilakis,Zdravko Kamenov,Philip Evans,Aleksandra Gilis-Januszewska,K. Lalic,A. Jotic,P. Djordevic,V. Dimitrijevic-Sreckovic,U. Hühmer,B Kulzer,S. Puhl,Y. H. Lee-Barkey,Ala'a Alkerwi,Charles Abraham,Wendy Hardeman,Tania Acosta,Martin Adler,Noël C. Barengo,R. Barengo,J. M. Boavida,V. Christov,B. Claussen,Xavier Cos,S. Deceukelier,P. Djordjevic,Martin R. Fischer,R. Gabriel-Sanchez,Margalit Goldfracht,José Gómez,U. Handke,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,J. Huttunen,S. Karadeniz,Mykola Khalangot,D. Köhler,Veronika Kopp,P. Kronsbein,D. Kyne-Grzebalski,Nebojsa Lalic,Rüdiger Landgraf,C. McIntosh,A. C. Mesquita,D. Misina,F. Muylle,Anne Neumann,A. C. Paiva,Pia Pajunen,Markku Peltonen,L. Perrenoud,Andreas Pfeiffer,Auli Polonen,F. Raposo,T. Reinehr,Clyde C. Robinson,Ulrike Rothe,T. Saaristo,J. Scholl,S. Spiers,T. Stemper,B. Stratmann,Zbigniew Szybiński,Tsvetalina Tankova,V. Telle-Hjellset,G. Terry,Daniel Tolks,F. Toti,A. Undeutsch,C. Valadas,Dzilda Velickiene,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +99 more
TL;DR: In this article, a European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for type 2 diabetes (T2DM) prevention using SIGN criteria, and provided evidence-based recommendations for preventing T2DM.
Journal ArticleDOI
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.
Jaana Lindström,Anne Neumann,K. E. Sheppard,Aleksandra Gilis-Januszewska,Colin J Greaves,U. Handke,Pia Pajunen,S. Puhl,Auli Polonen,Aila Rissanen,Michael Roden,T. Stemper,V. Telle-Hjellset,Jaakko Tuomilehto,Dzilda Velickiene,Peter Schwarz,Tania Acosta,Martin Adler,Ala'a Alkerwi,Noël C. Barengo,R. Barengo,J. M. Boavida,Kate Charlesworth,V. Christov,B. Claussen,Xavier Cos,Emmanuel Cosson,S. Deceukelier,V. Dimitrijevic-Sreckovic,P. Djordjevic,Philip Evans,A. M. Felton,Martin R. Fischer,R. Gabriel-Sanchez,Margalit Goldfracht,José Gómez,M. Hall,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,U. Hühmer,J. Huttunen,A. Jotic,Zdravko Kamenov,S. Karadeniz,Nicholas Katsilambros,Mykola Khalangot,Katarzyna Kissimova-Skarbek,D. Köhler,Veronika Kopp,P. Kronsbein,B Kulzer,D. Kyne-Grzebalski,K. Lalic,N. Lalic,Rüdiger Landgraf,Y. H. Lee-Barkey,Stavros Liatis,Konstantinos Makrilakis,C. McIntosh,Martin McKee,A. C. Mesquita,D. Misina,F. Muylle,A. C. Paiva,Bernhard Paulweber,Markku Peltonen,L. Perrenoud,Andreas Pfeiffer,F. Raposo,T. Reinehr,Clyde C. Robinson,Ulrike Rothe,T. Saaristo,J. Scholl,S. Spiers,B. Stratmann,Julia Szendroedi,Zbigniew Szybiński,Tsvetalina Tankova,G. Terry,Daniel Tolks,F. Toti,A. Undeutsch,C. Valadas,Paul Valensi,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +91 more
TL;DR: A comprehensive approach to diabetes prevention should combine population based primary prevention with programmes targeted at those who are at high risk, and take account of the local circumstances and diversity within modern society (e.g. social inequalities).
Journal ArticleDOI
Quality Indicators for the Prevention of Type 2 Diabetes in Europe – IMAGE
Pia Pajunen,Rüdiger Landgraf,F. Muylle,Anne Neumann,Jaana Lindström,Peter Schwarz,Markku Peltonen,Tania Acosta,Martin Adler,Ala'a Alkerwi,Noël C. Barengo,R. Barengo,J. M. Boavida,Kate Charlesworth,V. Christov,B. Claussen,Xavier Cos,Emmanuel Cosson,S. Deceukelier,V. Dimitrijevic-Sreckovic,P. Djordjevic,Philip Evans,A. M. Felton,Martin R. Fischer,R. Gabriel-Sanchez,Aleksandra Gilis-Januszewska,Margalit Goldfracht,José Gómez,Colin J Greaves,M. Hall,U. Handke,Hans Hauner,J. Herbst,Norbert Hermanns,L. Herrebrugh,C. Huber,U. Hühmer,J. Huttunen,A. Jotic,Zdravko Kamenov,S. Karadeniz,N. Katsilambros,Mykola Khalangot,Katarzyna Kissimova-Skarbek,D. Köhler,Veronika Kopp,P. Kronsbein,B Kulzer,D. Kyne-Grzebalski,K. Lalic,N. Lalic,Y. H. Lee-Barkey,Stavros Liatis,Konstantinos Makrilakis,C. McIntosh,Martin McKee,A. C. Mesquita,D. Misina,A. C. Paiva,B. Paulweber,L. Perrenoud,Andreas Pfeiffer,Auli Polonen,S. Puhl,F. Raposo,T. Reinehr,Aila Rissanen,Clyde C. Robinson,Michael Roden,Ulrike Rothe,T. Saaristo,J. Scholl,K. E. Sheppard,S. Spiers,T. Stemper,B. Stratmann,Julia Szendroedi,Zbigniew Szybiński,Tsvetalina Tankova,V. Telle-Hjellset,G. Terry,Daniel Tolks,F. Toti,Jaakko Tuomilehto,A. Undeutsch,C. Valadas,Paul Valensi,Dzilda Velickiene,P. Vermunt,R. Weiss,Johan Wens,Temel Yilmaz +91 more
TL;DR: The background and the methods used in the development of the IMAGE project quality indicators for diabetes primary prevention programs are described, which constitute the minimum level of quality assurance recommended for diabetes prevention programs.
Journal ArticleDOI
Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia).
Noël C. Barengo,Noël C. Barengo,Tania Acosta,Astrid Arrieta,Carlos Ricaurte,Diana Mayor,Jaakko Tuomilehto +6 more
TL;DR: The FINDRISC was found to be a useful tool to identify people with GMD and 2% of all screened participants had undetected T2D and 7% GMD.
Journal ArticleDOI
Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.
Rafael Gabriel,Nisa Boukichou Abdelkader,Tania Acosta,Aleksandra Gilis-Januszewska,Ricardo Gómez-Huelgas,Konstantinos Makrilakis,Zdravko Kamenov,B. Paulweber,Ilhan Satman,P. Djordjevic,Abdullah Alkandari,Asimina Mitrakou,Nebojsa Lalic,Stephen Colagiuri,Jaana Lindström,Jesús Egido,Andrea Natali,J. Carlos Pastor,Yvonne Teuschl,Marcus Lind,Luís Silva,Ruy Lopez-Ridaura,Jaakko Tuomilehto +22 more
TL;DR: ePREDICE is the first -randomized clinical trial with the aim to assess effects of different interventions (lifestyle and pharmacological) on microvascular function in people with pre-diabetes and will provide novel data on lifestyle modification combined with glucose lowering drugs for the prevention of early microv vascular complications and diabetes.